Pharmacognostical, Phytochemical Evaluation and Unlocking the Pharmacological Power of Pyrus communis L. Leaf Extract on DOCA Salt Induced Hypertension in Wistar Rats
Authors
-
Department of Pharmacy, Annamalai University, Chidambaram – 608002, Tamil Nadu ,IN
T. Malathi -
Department of Pharmacy, Annamalai University, Chidambaram – 608002, Tamil Nadu ,INT. Sivakkumar
-
Senghundhar College of Pharmacy, Namakkal – 637205, Tamil Nadu ,INM. Surendra Kumar
DOI:
https://doi.org/10.18311/jnr/2024/43899Keywords:
Pyrus communis L., Transversal Section, Quantitative Microscopy, Histochemical Test, DOCA Salts, Hypertensive RatAbstract
Objectives: Identification of the active ingredient in medication is greatly aided by pharmacognostical and phytochemical research, such as the macroscopic, GC-MS analysis and to study hypertensive treatment with ethanolic extract of Pyrus communis L. Methods: Transverse sections, powder microscopy, Histochemical analysis also performed preliminary phytochemical analysis and GC-MS of P. communis. The different groups of Wistar rats were administered 400mg/kg as a lower dose and 600mg/kg as a higher dose given DOCA salt-induced hypertension. Results: Histochemical analysis of this leaf shows the presence of cutin, mucilage cells, tannin, alkaloids, lignin, starch grains, calcium oxalates cluster crystals, and oils. Eleven components in the extract were reported via GC-MS. This report confirms the existence of various phytocomponents which are 4-pyridine methanol; N-Methylmaleimide; 4-acetyl-1h-pyrroline-2-carbaldehyde; Carbamic acid, 2-(Dimethyl amino) Ethyl Ester; 5-Acetyl-4-Amino-3-(2-Dimethylaminoethylthio)Thieno[3,2-C]Isothiazole; Cyclobutaneoctol; 1,3-Propane diamine, N, N’-Bis (3-Aminopropyl)-; Arginine; 9-Methyl-11-Oxo-1,6-Diaza tricyclo [7.2.0.0(6,8)] Undecane; Egtazic Acid; animal study significantly reduced the pressure compared to the control group. P. communis ethanolic extract possesses a significant (p≤0.05) reduction in hypertensive rats from measurements of control group as 157/137 mmHg systolic and diastolic blood pressure to 140/98 mmHg in 600 mg/kg Conclusions: These results will also be helpful to add to the advanced knowledge of P. communis standardisation and identification, which are essential components in separating real Pyrus species from adulterants and imitations in the herbal medicine formulations better for the treatment of hypertension. The empirical and phytochemical study of P. communis leaf holds significant potential for the development of novel herbal remedies for hypertensive patients.
Downloads
Metrics
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 T. Malathi, T. Sivakkumar, M. Surendra Kumar (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2024-06-28
Published 2024-08-31
References
Sapna S, Avinash K, Mukul T, Pathak AK. Pharmacognostic and phytochemical investigation of Stevia rebaudiana. Pharmacogn Mag. 2008; 4(13):89-94.
Kotnis MS, Patel P, Menon SN, Sane RT. Renoprotective effect of Hemidesmus indicus: A herbal drug used in gentamicin induced renal toxicity. Nephrol. 2004; 9(3):14252. https://doi.org/10.1111/j.1440-1797.2004.00247.x PMid:15189175
Hedrick UP, Howe GH, Taylor OM, Francis EH, Tukey HB. The pears of New York. 29th Annual Report, New York Department of Agriculture, New York; 1921. https://doi.org/10.5962/bhl.title.7037
Viadyaratnan PS, Arya VS. Indian medicinal plants, a compendium of 500 species, Vol 3. Orient Longman Ltd.; 1995.
World Health Organization (WHO). Quality assurance of pharmaceuticals: A compendium of guidelines and related materials, good manufacturing practices and inspection. Geneva: WHO; 1996a.
World Health Organization (WHO). Guidelines for the assessment of herbal medicines. WHO Technical Report Series. Geneva: WHO; 1996b.
Petkou D, Diamantidis G, Vasilakakis M. Arbutin oxidation by pear (Pyrus communis L.) peroxidises. Plant Sci. 2002; 162:115-19. https://doi.org/10.1016/S0168-9452(01)00539-8
Veltman RH, Sanders MG, Persiji ST, Peppelenbos HW, Oosterhaven J. Decreased ascorbic acid levels and brown core development in pears (Pyrus communis L. cv Conference). Physiol Plant. 1999; 107:39-45. https://doi.org/10.1034/j.1399-3054.1999.100106.x
Rychlinska I, Gudej J. Flavonoid compounds from Pyrus communis L. flowers. Instit Technol Chem Drug. 2002; 59:53-6.
Venkatesh S, Bolleddu R, Shivani Y, Alvala RK, Zareen N. Pharmacognostical, phytochemical, in vitro hypoglycemic studies of Avartani (Helicteres isora L.) root and fruit extracts. J Ayurveda. 2024; 18:5-13.
Wallis TE. Analytical microscopy - Its aims and methods in relation to foods, water, spices and drugs. Third Edition. Boston: Little, Brown and Company; 1965.
Khandelwal KR. Practical pharmacognosy, 19th edition, Niraliprakashan; 2008.
Fahn A. Plant anatomy. Third Edition Pergamon Press, Oxford; 1980. p. 360-495.
Zamani A, Attar F, Ghahreman A, Maroofi H. Anatomical studies of the genus Pyrus L. (Rosaceae) in Iran and its taxonomical implications. Iran J Bot. 2008; 14(2):132-42.
Iyengar MA, Pharmacognosy of powdered crude drugs. Manipal Power Press, Manipal; 1980. p. 1-73
Sass JE. Botanical microtechnique. Oxford and IBH Publishing Co. Calcutta; 1958. p. 1-248. https://doi.org/10.31274/isudp.25
Verma C, Ahmad R, Singh A. Physiochemical screening of Carica papaya leaves with specific reference to their pharmacognostical evaluation. Int J Pharm Biol Sci Arch. 2020; 11(1):21-7.
Kaur R, Arya V. Ethnomedicinal and phytochemical perspectives of Pyrus communis (L). J Pharmacogn Phytochem. 2012; 1:14-19.
Gibson AR, Clancy RL. An Australian exclusion diet. Med J Aust. 1978; 1(5):290-2. https://doi.org/10.5694/j.1326-5377.1978.tb112553.x PMid:661687
Khare CP. Indian medicinal plants: An illustrated dictionary. Springer Science, Springer Verlag, Germany: Berlin/Heidelberg; 2007. https://doi.org/10.1007/978-0387-70638-2 PMCid:PMC2705749
Petkou D, Diamantidis G, Vasilakakis M. Arbutin oxidation by pear (Pyrus communis L.) peroxidases. Plant Sci. 2002; 162:115-19. https://doi.org/10.1016/S0168-9452(01)00539-8
Rychlinska I, Gudej J. Flavonoid compounds from Pyrus communis (L.) flowers. Acta Polon Pharmaceu-Drug Res. 2002; 59:53-6.
Rehder A. Manual of cultivated trees and shrubs. Edition 2nd, Dioscorides Press, Portland; 1986. p. 401‐6.
Cinnasamy VM, Bhargava A. Wound healing activity of various extracts of fruits of Pyrus communis (L) in normal rats. J Pharmaceu Sci Inn. 2014; 3(2):148-53. https://doi.org/10.7897/2277-4572.032127
The Wealth of India. Raw materials, a dictionary of Indian raw materials and industrial products, National Institute of Science Communication, Council of Science and Industrial Research, New Delhi. 1998; 6:31-4.
Khare CP. Indian medicinal plants: Illustrated dictionary. First Indian Reprint, Springer (India) Pvt. Ltd., India: New Delhi; 2007. p. 717-18.
Petkou D, Diamantidis G, Vasilakakis M. Arbutin oxidation by pear (Pyrus communis L.) peroxidases. Plant Sci. 2002; 162:115-19. https://doi.org/10.1016/S0168-9452(01)00539-8
Veltman RH, Kho RM, Schaik ACRV, Sanders MG, Oosterhaven J. Ascorbic acid and tissue browning in pears (Pyrus communis L. cvs Rocha and Conference) under controlled atmosphere conditions. Postharvest Biol Tec. 2000; 19:129‐37. https://doi.org/10.1016/S0925-5214(00)00095-8
Hamauzu Y, Forest F, Hiramatsu K, Sugimoto M. Effect of pear (Pyrus communis L.) procyanidins on gastric lesions induced by HCl/ethanol in rats. Food Chem 2007; 100: 255‐63. https://doi.org/10.1016/j.foodchem.2005.09.050
Challice JS, Westwood MNW. Phenolic compounds of the genus Pyrus. Phytochem. 1972; 11:37‐44. https://doi.org/10.1016/S0031-9422(00)89964-1
Mehta BK, Verma M, Jafri M, Neogi R, Desiraju S. Triterpenoids from the stembark of Pyrus communis. Nat Prod Res. 2003; 6:459‐63. https://doi.org/10.1080/1478641031000149821 PMid:14577699
Kaur R, Arya V. Ethnomedicinal and phytochemical perspectives of Pyrus communis Linn. J Pharmacogn Phytochem. 2012; 1:14-19
Kokate CK. Textbook of practical pharmacognosy, Vallabh Prakashan, 3rd edition, India: New Delhi; 1994. p. 107-11, 115-25.
Li X, Zhang JY, Gao WY, Wang Y, Wang HY, Cao JG, et al. Chemical composition and anti-inflammatory and antioxidant activities of eight pear cultivars. J Agric Food Chem. 2012; 60:8738-44. https://doi.org/10.1021/jf303235h PMid:22880800
Pannu AS, Parle M. Anti-psychotic activity of Pyrus communis juice. Int J Pharm Pharm Sci. 2017; 9(4): 113-20. https://doi.org/10.22159/ijpps.2017v9i4.14541
Phillipson JD. Phytochemistry and medicinal plants. Phytochem. 2001; 56:237-43. https://doi.org/10.1016/ S0031-9422(00)00456-8 PMid:11243450
Ghazouani T, Talbi W, Sassi CB, Fattouch S. Chapter 41 – Pears. Nutritional Composition and Antioxidant Properties of Fruits and Vegetables. 2020. p. 671-80. https://doi.org/10.1016/B978-0-12-812780-3.00041-6
Tiernan AM. Behaviorial risk factor in breast cancer: Can risk be modified. The Oncolog. 2003; 8:326-34. https://doi.org/10.1634/theoncologist.8-4-326 PMid:12897329
Yang Y, Wel S, Mengjie Z, Guixing R. Phenolic composition and antioxidant activities of celery cultivars. J Food Sci. 2010; 75(1):C9-13 https://doi.org/10.1111/j.1750-3841.2009.01392.x
Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, Kaempfrol, luteolin and Apigenin) content of edible tropical plants. J Agric Food Chem. 2001; 49(6):3106-12. https://doi.org/10.1021/jf000892m PMid:11410016
Sylvester PW. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Drug Des Discov. 2011; 716:157-68. https://doi.org/10.1007/978-1-61779-012-6_9 PMid:21318905
Arunasree KM. Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomed. 2010; 17(8-9):581-8. https://doi.org/10.1016/j.phymed.2009.12.008 PMid:20096548
Pei W, Chong B, Quan YX, Tian YX, Ding FS, Jean S, et al. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats. Clin Exp Pharmacol Physiol. 2010; 37:894-9. https://doi.org/10.1111/j.1440-1681.2010.05402.x PMid:20456420
Veeramani C, Aristatle B, Pushpavalli G, Pugalendi KV. Antihypertensive efficacy of Melothria maderaspatana leaf extract on sham-operated and uninephrectomized DOCAsalt hypertensive rats. J Basic Clin Physiol Pharmacol. 2010; 21(1):27-41. https://doi.org/10.1515/JBCPP.2010.21.1.27 PMid:20506687
0.35
24
0.161